P/E ratio for U.S. Physical Therapy (USPH)
P/E ratio as of May 2023 (TTM): 47.0
According to U.S. Physical Therapy's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 47.0231. At the end of 2021 the company had a P/E ratio of 39.5.
P/E ratio history for U.S. Physical Therapy from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 39.5 | -18.57% |
| 2020 | 48.5 | 3.89% |
| 2019 | 46.7 | -40.26% |
| 2018 | 78.1 | 89.37% |
| 2017 | 41.3 | 14.02% |
| 2016 | 36.2 | 19.32% |
| 2015 | 30.3 | 18.54% |
| 2014 | 25.6 | -23.08% |
| 2013 | 33.3 | 83.59% |
| 2012 | 18.1 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 DaVita DVA | 16.9 | -64.02% | 🇺🇸 USA |
 Acadia Healthcare
ACHC | 22.5 | -52.25% | 🇺🇸 USA |
 Select Medical Holdings SEM | 19.1 | -59.35% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.